News & Press Releases

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing. 

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch. 

International Life Sciences Chair Cheryl Reicin was a guest on The Deal's “Drinks with The Deal” podcast, where she discussed her career journey and shared advice for those looking to make an impact in the field. 

Michael T. Renaud, Chair of Mintz’s Intellectual Property Division, has been named to Bloomberg Law’s 2025 Unrivaled Litigators list. The inaugural award celebrates litigators at law firms and elsewhere who lead the legal industry in high-stakes trials and settlements on impactful matters for clients.

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

ESG Practice Co-chair Jacob Hupart was quoted in a recent Agenda article discussing how companies are approaching the disclosure of climate-related targets amid a shifting political landscape.